Call For Abstracts

Abstracts will be available to the conference attendees via the conference app and virtual platform. Abstracts should be a maximum of 250 words which does not include title and authors. The deadline for abstract submission is January 10, 2024.

Submissions may be made under the Abstract Submissions tab on the RWCS 2024 website.


Any exhibit, of which the cost is underwritten to any extent by a pharmaceutical company or other commercial enterprise, must avoid commercialism. Trade names must not be used for drugs, devices and/or instrumentation including lasers. In addition, such an exhibit should include a clear but inconspicuous acknowledgment stating that a portion of its cost was underwritten and identify the particular commercial company involved. No advertising matter of any kind may be distributed nor will any material display which, in any way, directly promotes the commercial interest of any particular company, enterprise, or the exhibitor be permitted. Any medications or other substances, devices or equipment referred to in exhibit materials must be identified by their scientific names.

Note: Sponsorship or funding by a commercial enterprise must be noted in the lower right hand corner of the exhibit. Failure to do so will result in the exhibit being taken down.


Should you need further information, please contact:
Nicole Gomez, Meeting Manager, by email at


Click HERE for questions or to request additional information regarding the 2024 RWCS Symposia.